Sign in

You're signed outSign in or to get full access.

Troy Wichterman

Chief Financial Officer at BIOLIFE SOLUTIONSBIOLIFE SOLUTIONS
Executive

About Troy Wichterman

BioLife Solutions’ Chief Financial Officer since November 2021, age 40, with prior roles in finance at Ventas (public healthcare REIT), Heitman (private equity real estate), and PwC; he holds BBA and MAcc degrees from the University of Wisconsin–Madison and is a CPA (inactive) . Under his tenure, the company’s 2024 performance achieved 88% of compensation plan objectives, driven by revenues of $82 million and Adjusted EBITDA margin of 21% of revenue; this marked a sharp improvement from 2023 Adjusted EBITDA of $(4.664) million and a −3.3% margin when no cash bonuses were paid due to missing financial targets . Governance signals show an 82.4% 2023 say-on-pay approval and a firm prohibition on hedging and pledging of company securities for executives .

Past Roles

OrganizationRoleYearsStrategic Impact
BioLife Solutions (BLFS)Chief Financial OfficerNov 2021–present Oversees finance and accounting; integration of acquired businesses; SEC reporting; FP&A; operational finance; audit compliance
BioLife Solutions (BLFS)Vice President, FinanceNov 2019–Nov 2021 Led integration, acquisition due diligence and deal structure; SEC reporting; FP&A; operational finance; audit compliance
BioLife Solutions (BLFS)Director, FP&AJun 2016–Nov 2019 Built and led FP&A processes; supported operating and strategic planning
BioLife Solutions (BLFS)Financial AnalystFeb 2015–Jun 2016 Supported analysis across finance, reporting and operations
Ventas (NYSE: VTR)Senior Financial Analyst, AcquisitionsJan 2013–Sep 2014 Acquisitions analytical support at a public healthcare REIT
HeitmanSenior Portfolio AnalystJun 2009–Jan 2013 Portfolio analytics for a private equity REIT
PwCAuditing Associate2008–2009 Audit experience foundational to reporting rigor

External Roles

No external public company directorships or committee roles disclosed for Mr. Wichterman in the proxy materials .

Fixed Compensation

YearBase Salary ($)Target Bonus % of SalaryActual Cash Bonus Paid ($)Overall Payout % of Base Salary
2024472,000 60% 249,216 53%
2023472,000 60% 0 (no bonus paid) 0%
2022375,000 121,688 (non‑equity incentive)

Performance Compensation

Annual Cash Incentive – 2024 Company Objectives and Payouts

MetricTarget/ThresholdActual ResultPayout Contribution (%)
RevenueMaximum threshold $81M $82M 39%
Adjusted EBITDA margin (ex‑exec bonus)Maximum threshold 16% 21% of revenue 39%
Remediation of material weaknessesFull remediation target Prior weaknesses remediated; one new weakness in 2024 10%
NetSuite MRP module (Media)Implementation target Not fully implemented 0%
Overall payout vs targetAchieved 88% of target 88%

Equity Awards – Grants and Vesting

Award TypeGrant DateTarget Shares (#)Grant Date Fair Value ($)Vesting / Performance Conditions
Market‑based RSUs3/8/2024 41,715 1,096,270 TSR vs 20‑company peer group; 0–200% payout with thresholds at 30th–80th percentiles; performance period 1/1/2024–12/31/2025
Service‑vesting RSUs3/8/2024 41,715 724,172 25% vest at 1‑year anniversary; remainder quarterly over 3 years, subject to continued service
Market‑based RSAs (prior)1/3/2023 34,296 890,324 market/payout value at 12/31/2024 TSR peer‑group condition; 0–200% payout over 1/1/2023–12/31/2024
Service‑vesting RSAs (prior)1/3/2023 19,292 500,820 market value at 12/31/2024 Quarterly vesting over remaining schedule, subject to service

Option Exercises and Stock Vested

Metric20232024
Shares acquired on option exercise (#)938
Value realized on option exercise ($)17,466
Shares acquired on vesting (#)20,111 54,134
Value realized on vesting ($)364,238 970,911

Equity Ownership & Alignment

ItemDetail
Beneficial ownership (as of Jun 23, 2025)102,661 shares; less than 1% of outstanding; includes 2,144 shares issuable within 60 days via RS awards
Outstanding unvested equity (12/31/2024)Service RSAs: 355 (8/9/2021), 7,302 (2/24/2022), 19,292 (1/3/2023), 41,715 (3/8/2024); Market‑based RSAs: 34,296 (1/3/2023 target), 41,715 (3/8/2024 target)
Anti‑hedging/pledgingCompany prohibits executives from hedging or pledging company securities
Say‑on‑pay (2023)82.4% approval of votes cast

Outstanding Equity Awards at December 31, 2024 (Troy Wichterman)

Grant DateUnvested Shares (#)Market Value ($)Unearned Units (#)Market/Payout Value ($)
8/9/2021355 9,216
2/24/20227,302 189,560
1/3/202319,292 500,820 34,296 890,324
3/8/202441,715 1,082,921 41,715 1,082,921

Notes: Market values reflect $25.96 closing price on 12/31/2024 . 2024 service RSUs vest 25% at one year then quarterly over three years . 2024 market‑based RSUs vest 0–200% based on TSR percentile vs peer group (performance period 1/1/2024–12/31/2025) . 2023 market‑based RSAs had performance period 1/1/2023–12/31/2024 .

Employment Terms

TermDetails
Employment agreementEffective Nov 4, 2021; amended Jun 1, 2023 and Aug 15, 2023
“Good reason” definition (summary)Material breach; significant diminution of role; material pay/bonus reduction (not broad reductions); failure to assume agreement by successor; relocation >50 miles
Severance (termination without cause or resignation for good reason; outside CoC, modeled at 12/31/2024)Base salary $472,000; accelerated vesting of equity $3,755,763; COBRA $22,714; total $4,250,477
Severance (termination upon/within 12 months after CoC; modeled at 12/31/2024)Base salary $472,000; 2024 annual cash incentive $249,216; accelerated vesting of equity $3,755,763; COBRA $22,714; total $4,499,693
Tax gross‑upsCOBRA premiums include a tax gross‑up per employment agreements
Equity accelerationFull vesting of all unvested equity upon qualifying termination (both outside CoC and within 12 months post‑CoC)
Trigger structureDouble‑trigger CoC severance (requires qualifying termination upon/within 12 months after CoC)

Additional compliance note: Company disclosed late Section 16(a) Form 4 filings for Troy Wichterman on April 23, 2024 and September 18, 2024 (among several officers), indicating timing lapses in reporting .

Investment Implications

  • Alignment and upside participation: High equity exposure via time‑based and market‑based RSUs, with TSR‑linked payout up to 200%, aligns incentives with shareholder returns; 2024 cash plan tied to revenue and Adjusted EBITDA drove meaningful improvement versus 2023 .
  • Retention and termination economics: Generous acceleration of all unvested equity on termination (outside and within CoC) plus 12 months’ salary and COBRA (with tax gross‑up) reduces forfeiture risk; this may lessen retention pressure but implies potential overhang in a sale scenario due to broad acceleration .
  • Trading/flow signals: Significant periodic RSU vesting (e.g., 54,134 shares vested in 2024) suggests potential supply around vest dates; absence of hedging/pledging mitigates alignment risks, but observed late Form 4s warrant monitoring for process discipline .
  • Governance: Say‑on‑pay support (82.4%) and peer benchmarking near the 50th percentile indicate shareholder acceptance of pay design, with explicit prohibitions on hedging, pledging, and option re‑pricing .